Summary
The influence of the antitumor agent titanocene dichloride on the morphologic appearance of a heterotransplanted human colon adenocarcinoma was investigated. The first alterations in tumor cells manifested 12 h after administration of a single dose (40 mg/kg) and consisted of nuclear changes, such as chromatin condensation, enlargement of the nuclear envelope, structural changes of the nucleoli, and formation of segmented nuclei 12 h later; bundles of microfilaments, lipid droplets and inclusion bodies, often containing cellular debris, occurred in the cytoplasm. Intracytoplasmic virus particles of type A were detectable. They were obviously extruded into the extracellular space by a budding process and became extracellular virus particles of type C. Within 24 h after treatment, the mitotic index decreased from 2.5% to 0.3%. Whereas after administration of a single dose, recovery phenomena took place between 2 and 4 days, the severe destruction induced by 3-fold doses of titanocene dichloride (3×30 mg/kg), was apparently not reversible. These results confirm the tumor-inhibiting potency of titanocene dichloride against human colon adenocarcinoma and underline the discriminatory power of morphologic studies in the preclinical evaluation of cytostatic drugs against heterotransplanted human tumors.
Similar content being viewed by others
References
Aaronson SA, Todaro GJ, Scolnick EM (1971) Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells. Science 174:157–159
Azar HA, Fernandez SB, Bros LM, Sullivan JL (1982) Human tumor xenografts in athymic (nude) mice: chemotherapy trials in serially transplanted tumors. Ann Clin Lab Sci 12:51–59
Bauer H (1974) Virion and tumor cell antigens of C-type RNA tumor viruses. Adv Cancer Res 20:275–341
Ben-Ze'ev A (1985) The cytoskeleton in cancer cells. Biochim Biophys Acta 780:197–212
Berenbaum MC, Sheard CE, Reittie JR, Bundick RV (1974) The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer 30:13–32
Bernhard W (1960) The detection and study of tumor viruses with the electron microscope. Cancer Res 20:712–726
Chopra HC, Mason MM (1970) A new virus in a spontaneous mammary tumor of a rhesus monkey. Cancer Res 30:2081–2086
Köpf-Maier P (1982) Development of necroses, virus activation and giant cell formation after treatment of Ehrlich ascites tumor with metallocene dichlorides. J Cancer Res Clin Oncol 103:145–164
Köpf-Maier P (1986) Dying and regeneration of human tumor cells after heterotransplantation to athymic mice. Histol Histopathol 1:383–390
Köpf-Maier P (1987) Tumor inhibition by titanocene complexes: influence upon xenografted human lung carcinomas. J Cancer Res Clin Oncol 113:342–348
Köpf-Maier P, Hermann G (1984) Cytologic observations on the effects of metallocene dichlorides on human fibroblasts cultivated in citro. Virchows Arch [Cell Pathol] 47:107–122
Köpf-Maier P, Köpf H (1980) Tunor inhibition by titanocene dichloride: first clues to the mechanism of action. Naturwissenschaften 67:415–416
Köpf-Maier P, Köpf H (1987) Tumor inhibition by titanocene complexes: activity against B16 melanoma and colon 38 carcinoma. Drugs Res (Arzneim-Forsch) 37:532–534
Köpf-Maier P, Krahl D (1983) Tumor inhibition by metallocenes: ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy. Chem Biol Interact 44:317–328
Köpf-Maier P, Hesse B, Köpf H (1980) Tumorhemmung durch Metallocene: Wirkung von Titanocen-, Zirconocen- und Hafnocendichlorid gegenüber Ehrlich-Aszites-Tumor der Maus. J Cancer Res Clin Oncol 96:43–51
Köpf-Maier P, Wagner W, Köpf H (1981a) Different inhibition pattern of the nucleic acid metabolism after in vitro treatment with titanocene and vanadocene dichlorides. Naturwissenschaften 68:272–273
Köpf-Maier P, Wagner W, Liss E (1981b) Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diaminedichloroplatinum(II) and metallocene dichlorides. J Cancer Res Clin Oncol 102:21–30
Köpf-Maier P, Wagner W, Liss E (1983) Induction of cell arrest at G1/S and in G2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro. J Cancer Res Clin Oncol 106:44–52
Köpf-Maier P, Moormann A, Köpf H (1985) Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice. Eur J Cancer Clin Oncol 21:853–857
Köpf-Maier P, Preiss F, Marx T, Klapötke T, Köpf H (1986) Tumor inhibition by titanocene complexes: activity against sarcoma 180. Anticancer Res 6:33–38
Kyriazis AA, Kyriazis AP, Kereiakes JG, Soloway MS, McCombs WB (1983) Histopathologic evaluation of response of treatment of human tumors grown in the nude mouse. Exp Cell Biol 51:83–95
Lowy DR, Rowe WP, Teich N, Hartley JW (1971) Murine leukemia virus: high-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine. Science 174:155–156
Nakata Y, Ochi T, Kurisaki E, Okano H, Hamada H, Amitani K, Shizuo T, Ono K, Sakamoto Y (1980) Identification of type A and type C virus particles in BF murine osteosarcoma. Cancer Res 40:127–132
Povlsen CO, Jacobsen GK (1975) Chemotherapy of a human malignant melanoma transplanted in the nude mouse. Cancer Res 35:2790–2796
Schidlovsky G, Shibley GP, Benton CV, Elser JE (1978) Type B and type C RNA tumor virus replication in single cells. Electron microscopy with tannic acid. J Natl Cancer Inst 61:91–95
Wyllie AH, Kerr JFR, Currie AR (1980) Cell death: the significance of apoptosis. Int Rev Cytol 68:251–306
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Köpf-Maier, P. Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with titanocene dichloride. J Cancer Res Clin Oncol 114, 250–258 (1988). https://doi.org/10.1007/BF00405830
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00405830